RBBP9 Antikörper (AA 1-186) (HRP)
Kurzübersicht für RBBP9 Antikörper (AA 1-186) (HRP) (ABIN7166722)
Target
Alle RBBP9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-186
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Antigen Affinity Purified
-
Immunogen
- Recombinant Human Putative hydrolase RBBP9 protein (1-186AA)
-
Isotyp
- IgG
-
-
anti-Retinoblastoma Binding Protein 9 (RBBP9) (AA 1-186) antibody
RBBP9 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Retinoblastoma Binding Protein 9 (RBBP9) (AA 87-185) antibodyRBBP9 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 2A11 unconjugated
anti-Retinoblastoma Binding Protein 9 (RBBP9) (AA 1-186) antibodyRBBP9 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Retinoblastoma Binding Protein 9 (RBBP9) (AA 1-186) antibodyRBBP9 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 3H4 unconjugated
anti-Retinoblastoma Binding Protein 9 (RBBP9) (AA 87-185) antibodyRBBP9 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2A11 unconjugated
anti-Retinoblastoma Binding Protein 9 (RBBP9) (N-Term) antibodyRBBP9 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Meerschweinchen, Pferd, Kaninchen, Zebrafisch (Danio rerio) WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Retinoblastoma Binding Protein 9 (RBBP9) antibodyRBBP9 Reaktivität: Human WB, IHC, IF, FACS Wirt: Maus Monoclonal 4G9 unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- RBBP9 (Retinoblastoma Binding Protein 9 (RBBP9))
-
Andere Bezeichnung
- RBBP9
-
Hintergrund
-
Background: May play a role in the transformation process due to its capacity to confer resistance to the growth-inhibitory effects of TGF-beta1 through interaction with retinoblastoma and the subsequent displacement of E2F-1.
Aliases: B5T overexpressed gene protein antibody, B5T-overexpressed gene protein antibody, BOG antibody, Bog protein antibody, MGC9236 antibody, OTTHUMP00000030360 antibody, Protein BOG antibody, Putative hydrolase RBBP9 antibody, RBBP 10 antibody, RBBP 9 antibody, RBBP-10 antibody, RBBP-9 antibody, RBBP10 antibody, RBBP9 antibody, RBBP9_HUMAN antibody, Retinoblastoma binding protein 10 antibody, Retinoblastoma binding protein 9 antibody, Retinoblastoma-binding protein 10 antibody, Retinoblastoma-binding protein 9 antibody, Retinoma binding protein 9 antibody
-
UniProt
- O75884
Target
-
